GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Protalix Biotherapeutics PLX · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.57

+1.18%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Protalix Biotherapeutics

Our reporting

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -0.02 a share on revenue of $12.4m.

Past results

Reported against what analysts expected

12 Aug 202613 May 20268 May 202618 Mar 202613 Nov 202514 Aug 2025
Earnings per share0.050.22-0.05-0.070.030.00
Forecast-0.01-0.01-0.010.010.060.03
Revenue$19.9m$33.8m—$9.1m$17.9m$15.7m
Forecast$12.9m$11.5m—$18.3m$14.2m$13.5m

Key events

  1. 20 Dec 201910-to-1 reverse split
  2. 6 Sept 2010Listed
  3. 3 Jan 200710-to-1 reverse split

Protalix Biotherapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.